Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Verastem Shares Outstanding 2011-2024 | VSTM

Verastem shares outstanding from 2011 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Verastem Annual Shares Outstanding
(Millions of Shares)
2023 22
2022 16
2021 15
2020 13
2019 6
2018 6
2017 3
2016 3
2015 3
2014 2
2013 2
2012 2
2011 0
2010
Verastem Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 27
2024-03-31 27
2023-12-31 22
2023-09-30 27
2023-06-30 18
2023-03-31 17
2022-12-31 16
2022-09-30 16
2022-06-30 16
2022-03-31 16
2021-12-31 15
2021-09-30 15
2021-06-30 14
2021-03-31 14
2020-12-31 13
2020-09-30 14
2020-06-30 14
2020-03-31 9
2019-12-31 6
2019-09-30 6
2019-06-30 6
2019-03-31 6
2018-12-31 6
2018-09-30 6
2018-06-30 5
2018-03-31 4
2017-12-31 3
2017-09-30 3
2017-06-30 3
2017-03-31 3
2016-12-31 3
2016-09-30 3
2016-06-30 3
2016-03-31 3
2015-12-31 3
2015-09-30 3
2015-06-30 3
2015-03-31 3
2014-12-31 2
2014-09-30 2
2014-06-30 2
2014-03-31 2
2013-12-31 2
2013-09-30 2
2013-06-30 2
2013-03-31 2
2012-12-31 2
2012-09-30 2
2012-06-30 2
2012-03-31 1
2011-12-31 0
2011-09-30 0
2011-06-30 0
2011-03-31 0
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.111B $0.003B
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $177.351B 17.75
Regeneron Pharmaceuticals (REGN) United States $128.364B 30.31
Vertex Pharmaceuticals (VRTX) United States $123.541B 0.00
Gilead Sciences (GILD) United States $103.534B 17.69
CSL (CSLLY) Australia $98.506B 0.00
Bristol Myers Squibb (BMY) United States $97.802B 35.21
GSK (GSK) United Kingdom $89.347B 10.36
Alnylam Pharmaceuticals (ALNY) United States $33.601B 0.00
Argenex SE (ARGX) Netherlands $32.037B 0.00
Biogen (BIIB) United States $28.825B 12.17
Moderna (MRNA) United States $26.785B 0.00
BioNTech SE (BNTX) Germany $24.965B 0.00
Illumina (ILMN) United States $20.112B 137.23
BeiGene (BGNE) Cayman Islands $19.043B 0.00
Genmab (GMAB) Denmark $17.520B 21.89
BioMarin Pharmaceutical (BMRN) United States $16.022B 47.40
Vaxcyte (PCVX) United States $12.738B 0.00
Insmed (INSM) United States $12.701B 0.00
Exact Sciences (EXAS) United States $12.452B 0.00
Incyte (INCY) United States $12.203B 792.00
Sarepta Therapeutics (SRPT) United States $11.953B 272.48
Bio-Techne Corp (TECH) United States $11.610B 45.47
QIAGEN (QGEN) Netherlands $10.399B 21.96
Legend Biotech (LEGN) United States $9.247B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.106B 30.17
Roivant Sciences (ROIV) United Kingdom $8.963B 0.00
Repligen (RGEN) United States $7.949B 121.31
Intra-Cellular Therapies (ITCI) United States $7.948B 0.00
Halozyme Therapeutics (HALO) United States $7.669B 20.18
Exelixis (EXEL) United States $7.505B 23.08
Viking Therapeutics (VKTX) United States $6.959B 0.00
Zealand Pharma (ZLDPF) Denmark $6.738B 0.00
Ascendis Pharma (ASND) Denmark $6.627B 0.00
Cytokinetics (CYTK) United States $6.361B 0.00
Krystal Biotech (KRYS) United States $5.621B 376.23
Ultragenyx Pharmaceutical (RARE) United States $5.330B 0.00
Blueprint Medicines (BPMC) United States $5.327B 0.00
Nuvalent (NUVL) United States $5.293B 0.00
Avidity Biosciences (RNA) United States $4.536B 0.00
Apellis Pharmaceuticals (APLS) United States $4.479B 0.00
Alkermes (ALKS) Ireland $4.374B 15.35
Axsome Therapeutics (AXSM) United States $4.358B 0.00
Immunovant (IMVT) United States $4.224B 0.00
ADMA Biologics Inc (ADMA) United States $4.114B 67.89
Arcellx (ACLX) United States $4.019B 0.00
Denali Therapeutics (DNLI) United States $4.003B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.903B 0.00
Biohaven (BHVN) United States $3.380B 0.00
Merus (MRUS) Netherlands $3.352B 0.00
Amicus Therapeutics (FOLD) United States $3.346B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.261B 0.00
Guardant Health (GH) United States $3.147B 0.00
IDEAYA Biosciences (IDYA) United States $3.051B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.015B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.983B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.907B 0.00
Bavarian Nordic (BVNRY) Denmark $2.779B 15.01
Celldex Therapeutics (CLDX) United States $2.768B 0.00
Kymera Therapeutics (KYMR) United States $2.762B 0.00
Protagonist Therapeutics (PTGX) United States $2.689B 17.42
Geron (GERN) United States $2.682B 0.00
SpringWorks Therapeutics (SWTX) United States $2.673B 0.00
Iovance Biotherapeutics (IOVA) United States $2.647B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.646B 88.61
Twist Bioscience (TWST) United States $2.611B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.436B 0.00
ImmunityBio (IBRX) United States $2.431B 0.00
Janux Therapeutics (JANX) United States $2.427B 0.00
Myriad Genetics (MYGN) United States $2.397B 0.00
CG Oncology (CGON) United States $2.336B 0.00
Structure Therapeutics (GPCR) United States $2.304B 0.00
Apogee Therapeutics (APGE) United States $2.214B 0.00
Vericel (VCEL) United States $2.171B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.146B 19.36
Keros Therapeutics (KROS) United States $2.116B 0.00
Intellia Therapeutics (NTLA) United States $2.100B 0.00
NeoGenomics (NEO) United States $2.076B 0.00
Zai Lab (ZLAB) China $2.053B 0.00
Beam Therapeutics (BEAM) United States $2.011B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.962B 0.00
Vera Therapeutics (VERA) United States $1.955B 0.00
Galapagos (GLPG) Belgium $1.931B 0.00
Novavax (NVAX) United States $1.908B 0.00
Neumora Therapeutics (NMRA) United States $1.893B 0.00
NovoCure (NVCR) Jersey $1.875B 0.00
Ligand Pharmaceuticals (LGND) United States $1.865B 31.71
Fortrea Holdings (FTRE) United States $1.847B 57.25
Akero Therapeutics (AKRO) United States $1.784B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.745B 0.00
Certara (CERT) United States $1.725B 56.42
Rocket Pharmaceuticals (RCKT) United States $1.724B 0.00
MannKind (MNKD) United States $1.705B 62.00
Arvinas (ARVN) United States $1.683B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.652B 0.00
Edgewise Therapeutics (EWTX) United States $1.648B 0.00
Arcus Biosciences (RCUS) United States $1.590B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.531B 0.00
Kura Oncology (KURA) United States $1.524B 0.00
Nurix Therapeutics (NRIX) United States $1.518B 0.00
Belite Bio (BLTE) United States $1.491B 0.00
Spyre Therapeutics (SYRE) United States $1.448B 0.00
Dynavax Technologies (DVAX) United States $1.438B 99.73
Disc Medicine (IRON) United States $1.435B 0.00
Viridian Therapeutics (VRDN) United States $1.323B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.294B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.294B 0.00
Gyre Therapeutics (GYRE) United States $1.283B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.230B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.206B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.200B 0.00
ANI Pharmaceuticals (ANIP) United States $1.181B 16.04
Phathom Pharmaceuticals (PHAT) United States $1.162B 0.00
Cogent Biosciences (COGT) United States $1.124B 0.00
Prothena (PRTA) Ireland $1.114B 0.00
Tyra Biosciences (TYRA) United States $1.085B 0.00
Vir Biotechnology (VIR) United States $1.074B 0.00
Tango Therapeutics (TNGX) United States $1.071B 0.00
Immatics (IMTX) Germany $1.055B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.051B 0.00
AnaptysBio (ANAB) United States $1.051B 0.00
Praxis Precision Medicines (PRAX) United States $1.042B 0.00
Cullinan Therapeutics (CGEM) United States $1.022B 0.00
CARGO Therapeutics (CRGX) United States $1.010B 0.00
Sana Biotechnology (SANA) United States $1.008B 0.00
Travere Therapeutics (TVTX) United States $0.964B 0.00
MiMedx (MDXG) United States $0.903B 25.62
Immunome (IMNM) United States $0.883B 0.00
Zymeworks (ZYME) United States $0.865B 0.00
Erasca (ERAS) United States $0.864B 0.00
Castle Biosciences (CSTL) United States $0.847B 0.00
Sinovac Biotech (SVA) China $0.844B 0.00
Dianthus Therapeutics (DNTH) United States $0.816B 0.00
Arbutus Biopharma (ABUS) United States $0.814B 0.00
ArriVent BioPharma (AVBP) United States $0.799B 0.00
89BIO (ETNB) United States $0.796B 0.00
AbCellera Biologics (ABCL) Canada $0.790B 0.00
Nuvation Bio (NUVB) United States $0.763B 0.00
Abivax SA (ABVX) France $0.757B 0.00
Liquidia Technologies (LQDA) United States $0.746B 0.00
WAVE Life Sciences (WVE) Singapore $0.731B 0.00
Mesoblast (MESO) Australia $0.727B 0.00
Stoke Therapeutics (STOK) United States $0.722B 0.00
Pliant Therapeutics (PLRX) United States $0.720B 0.00
Avid Bioservices (CDMO) United States $0.712B 0.00
Annexon (ANNX) United States $0.711B 0.00
Replimune (REPL) United States $0.709B 0.00
CureVac (CVAC) Germany $0.692B 0.00
Rapport Therapeutics (RAPP) $0.692B 0.00
Revance Therapeutics (RVNC) United States $0.688B 0.00
Olema Pharmaceuticals (OLMA) United States $0.679B 0.00
IGM Biosciences (IGMS) United States $0.676B 0.00
Humacyte (HUMA) United States $0.671B 0.00
Terns Pharmaceuticals (TERN) United States $0.669B 0.00
Scholar Rock Holding (SRRK) United States $0.661B 0.00
Oric Pharmaceuticals (ORIC) United States $0.639B 0.00
Adaptive Biotechnologies (ADPT) United States $0.634B 0.00
Cytek Biosciences (CTKB) United States $0.623B 0.00
ITeos Therapeutics (ITOS) United States $0.617B 0.00
REGENXBIO (RGNX) United States $0.602B 0.00
Astria Therapeutics (ATXS) United States $0.599B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.590B 0.00
Mineralys Therapeutics (MLYS) United States $0.576B 0.00
LENZ Therapeutics (LENZ) United States $0.568B 0.00
Applied Therapeutics (APLT) United States $0.560B 0.00
Allogene Therapeutics (ALLO) United States $0.556B 0.00
Entrada Therapeutics (TRDA) United States $0.553B 5.02
Q32 Bio (QTTB) United States $0.548B 0.00
Alector (ALEC) United States $0.546B 0.00
Third Harmonic Bio (THRD) United States $0.545B 0.00
Celcuity (CELC) United States $0.542B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.536B 0.00
Alumis (ALMS) United States $0.532B 0.00
Neurogene (NGNE) United States $0.524B 0.00
Pharming Group (PHAR) Netherlands $0.510B 0.00
ACELYRIN, INC (SLRN) United States $0.496B 0.00
PureTech Health (PRTC) United States $0.490B 0.00
Prime Medicine (PRME) United States $0.486B 0.00
Aura Biosciences (AURA) United States $0.486B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.475B 0.00
Contineum Therapeutics (CTNM) United States $0.464B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.446B 0.00
C4 Therapeutics (CCCC) United States $0.444B 0.00
Anavex Life Sciences (AVXL) United States $0.442B 0.00
GH Research (GHRS) Ireland $0.440B 0.00
Fate Therapeutics (FATE) United States $0.426B 0.00
GRAIL (GRAL) United States $0.421B 0.00
MaxCyte (MXCT) United States $0.421B 0.00
Absci (ABSI) United States $0.419B 0.00
Northwest Biotherapeutics (NWBO) United States $0.418B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.411B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.405B 0.00
Emergent Biosolutions (EBS) United States $0.404B 0.00
Nkarta (NKTX) United States $0.394B 0.00
CorMedix Inc (CRMD) United States $0.383B 0.00
G1 Therapeutics (GTHX) United States $0.377B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.366B 0.00
Sutro Biopharma (STRO) United States $0.365B 0.00
Anika Therapeutics (ANIK) United States $0.361B 174.43
Inozyme Pharma (INZY) United States $0.353B 0.00
Alto Neuroscience (ANRO) United States $0.350B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.348B 0.00
Ocugen (OCGN) United States $0.345B 0.00
Cartesian Therapeutics (RNAC) United States $0.344B 0.00
Nautilus Biotechnology (NAUT) United States $0.342B 0.00
Voyager Therapeutics (VYGR) United States $0.339B 22.21
Design Therapeutics (DSGN) United States $0.331B 0.00
XOMA Royalty (XOMA) United States $0.325B 0.00
Jasper Therapeutics (JSPR) United States $0.324B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.321B 0.00
Prima BioMed (IMMP) Australia $0.313B 0.00
Kamada (KMDA) Israel $0.312B 20.07
Atea Pharmaceuticals (AVIR) United States $0.310B 0.00
Editas Medicine (EDIT) United States $0.309B 0.00
Urogen Pharma (URGN) United States $0.306B 0.00
Instil Bio (TIL) United States $0.302B 0.00
Alimera Sciences (ALIM) United States $0.302B 0.00
AC Immune (ACIU) Switzerland $0.302B 0.00
Kyverna Therapeutics (KYTX) United States $0.302B 0.00
Solid Biosciences (SLDB) United States $0.298B 0.00
PepGen (PEPG) United States $0.295B 0.00
EnGene Holdings (ENGN) Canada $0.294B 0.00
TScan Therapeutics (TCRX) United States $0.293B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.291B 0.00
Rezolute (RZLT) United States $0.289B 0.00
Poseida Therapeutics (PSTX) United States $0.287B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.284B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.281B 0.00
Biomea Fusion (BMEA) United States $0.272B 0.00
MeiraGTx Holdings (MGTX) United States $0.271B 0.00
UniQure (QURE) Netherlands $0.270B 0.00
ChromaDex (CDXC) United States $0.266B 0.00
ScPharmaceuticals (SCPH) United States $0.266B 0.00
Artiva Biotherapeutics (ARTV) United States $0.261B 0.00
Tectonic Therapeutic (TECX) United States $0.258B 0.00
Precigen (PGEN) United States $0.251B 0.00
Alpha Teknova (TKNO) United States $0.243B 0.00
Zura Bio (ZURA) United States $0.242B 0.00
Abeona Therapeutics (ABEO) United States $0.242B 0.00
Trevi Therapeutics (TRVI) United States $0.240B 0.00
Amarin (AMRN) Ireland $0.239B 0.00
2seventy Bio (TSVT) United States $0.236B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.224B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.219B 0.00
Inhibrx Biosciences (INBX) $0.218B 0.00
Mersana Therapeutics (MRSN) United States $0.217B 0.00
Fulcrum Therapeutics (FULC) United States $0.215B 0.00
Compass Therapeutics (CMPX) United States $0.212B 0.00
Candel Therapeutics (CADL) United States $0.211B 0.00
XBiotech (XBIT) United States $0.208B 0.00
Scilex Holding (SCLX) United States $0.203B 0.00
Molecular Partners AG (MOLN) Switzerland $0.203B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
Gossamer Bio (GOSS) United States $0.199B 0.00
Cabaletta Bio (CABA) United States $0.197B 0.00
Codexis (CDXS) United States $0.194B 0.00
Greenwich LifeSciences (GLSI) United States $0.187B 0.00
Innate Pharma S.A (IPHA) France $0.185B 0.00
Opthea (OPT) Australia $0.184B 0.00
Caribou Biosciences (CRBU) United States $0.183B 0.00
DiaMedica Therapeutics (DMAC) United States $0.183B 0.00
Skye Bioscience (SKYE) United States $0.182B 0.00
Shattuck Labs (STTK) United States $0.176B 0.00
Compugen (CGEN) Israel $0.175B 0.00
Inovio Pharmaceuticals (INO) United States $0.172B 0.00
Generation Bio (GBIO) United States $0.169B 0.00
Sangamo Therapeutics (SGMO) United States $0.169B 0.00
Tenaya Therapeutics (TNYA) United States $0.163B 0.00
BioStem Technologies (BSEM) $0.161B 25.26
23andMe Holding (ME) United States $0.160B 0.00
Lifecore Biomedical (LFCR) United States $0.158B 0.00
Oncobiologics (OTLK) United States $0.154B 0.00
Actuate Therapeutics (ACTU) United States $0.152B 0.00
Ventyx Biosciences (VTYX) United States $0.152B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.151B 0.00
Coherus BioSciences (CHRS) United States $0.149B 0.00
Elutia (ELUT) United States $0.148B 0.00
Adherex Technologies (FENC) United States $0.147B 134.75
Acumen Pharmaceuticals (ABOS) United States $0.147B 0.00
Adverum Biotechnologies (ADVM) United States $0.147B 0.00
Vigil Neuroscience (VIGL) United States $0.146B 0.00
Seres Therapeutics (MCRB) United States $0.146B 0.00
ATyr Pharma (ATYR) United States $0.142B 0.00
Akoya Biosciences (AKYA) United States $0.139B 0.00
Invivyd (IVVD) United States $0.137B 0.00
Immunic (IMUX) United States $0.134B 0.00
Cellectis S.A (CLLS) France $0.133B 0.00
Adagene (ADAG) China $0.132B 0.00
Agenus (AGEN) United States $0.128B 0.00
Rani Therapeutics Holdings (RANI) United States $0.128B 0.00
Repare Therapeutics (RPTX) Canada $0.127B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Adicet Bio (ACET) United States $0.126B 0.00
Kodiak Sciences (KOD) United States $0.125B 0.00
Eton Pharmaceuticals (ETON) United States $0.125B 0.00
Puma Biotechnology (PBYI) United States $0.123B 13.21
Nuvectis Pharma (NVCT) United States $0.121B 0.00
Cardiff Oncology (CRDF) United States $0.119B 0.00
Inventiva S.A (IVA) France $0.118B 0.00
X4 Pharmaceuticals (XFOR) United States $0.114B 0.00
ALX Oncology Holdings (ALXO) United States $0.113B 0.00
PDS Biotechnology (PDSB) United States $0.112B 0.00
FibroBiologics (FBLG) United States $0.111B 0.00
Annovis Bio (ANVS) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
CervoMed (CRVO) United States $0.105B 0.00
Sagimet Biosciences (SGMT) United States $0.104B 0.00
Clearside Biomedical (CLSD) United States $0.101B 0.00
Seer (SEER) United States $0.101B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.100B 0.00
Checkpoint Therapeutics (CKPT) United States $0.099B 0.00
CytomX Therapeutics (CTMX) United States $0.098B 8.93
MediciNova (MNOV) United States $0.097B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.096B 0.00
Werewolf Therapeutics (HOWL) United States $0.094B 0.00
BioHarvest Sciences (CNVCF) Canada $0.093B 0.00
Genelux (GNLX) United States $0.092B 0.00
Renovaro (RENB) United States $0.092B 0.00
Coya Therapeutics (COYA) United States $0.091B 0.00
VistaGen Therapeutics (VTGN) United States $0.086B 0.00
HilleVax (HLVX) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
BeyondSpring (BYSI) United States $0.085B 0.00
InflaRx (IFRX) Germany $0.085B 0.00
I-Mab (IMAB) China $0.085B 0.00
Semper Paratus Acquisition (TVGN) United States $0.084B 0.00
BioAtla (BCAB) United States $0.084B 0.00
Benitec Biopharma (BNTC) United States $0.082B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Cidara Therapeutics (CDTX) United States $0.080B 0.00
Ovid Therapeutics (OVID) United States $0.079B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
Chimerix (CMRX) United States $0.078B 0.00
Precision BioSciences (DTIL) United States $0.076B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Adlai Nortye (ANL) Cayman Islands $0.072B 0.00
Leap Therapeutics (LPTX) United States $0.072B 0.00
Vor Biopharma (VOR) $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.072B 3.24
Boundless Bio (BOLD) United States $0.071B 0.00
DBV Technologies S.A (DBVT) France $0.071B 0.00
Omega Therapeutics (OMGA) United States $0.068B 0.00
Rapt Therapeutics (RAPT) United States $0.067B 0.00
Connect Biopharma Holdings (CNTB) United States $0.066B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.066B 0.00
Imunon (IMNN) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
TELA Bio (TELA) United States $0.064B 0.00
Bluebird Bio (BLUE) United States $0.063B 0.00
Aileron Therapeutics (ALRN) United States $0.062B 0.00
HOOKIPA Pharma (HOOK) United States $0.061B 0.00
Celularity (CELU) United States $0.061B 0.00
Affimed (AFMD) Germany $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Intensity Therapeutics (INTS) United States $0.058B 0.00
Gritstone Bio (GRTS) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.057B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Lexaria Bioscience (LEXX) Canada $0.056B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.055B 0.00
Aerovate Therapeutics (AVTE) United States $0.054B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.054B 0.00
Allakos (ALLK) United States $0.053B 0.00
IO Biotech (IOBT) Denmark $0.051B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.050B 0.00
Immix Biopharma (IMMX) United States $0.050B 0.00
LakeShore Biopharma (LSB) China $0.048B 0.00
Passage Bio (PASG) United States $0.046B 0.00
Rallybio (RLYB) United States $0.046B 0.00
Aligos Therapeutics (ALGS) United States $0.045B 0.00
CalciMedica (CALC) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Elicio Therapeutics (ELTX) United States $0.044B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Syros Pharmaceuticals (SYRS) United States $0.042B 0.00
Fortress Biotech (FBIO) United States $0.042B 0.00
Kezar Life Sciences (KZR) United States $0.041B 0.00
Clene (CLNN) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
Atara Biotherapeutics (ATRA) United States $0.040B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.039B 0.00
Bionano Genomics (BNGO) United States $0.039B 0.00
NextCure (NXTC) United States $0.039B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Dyadic (DYAI) United States $0.037B 0.00
Elevation Oncology (ELEV) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Eyenovia (EYEN) United States $0.035B 0.00
Ocuphire Pharma (OCUP) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
Quince Therapeutics (QNCX) United States $0.032B 0.00
ARCA Biopharma (ORKA) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Equillium (EQ) United States $0.031B 0.00
Lumos Pharma (LUMO) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.029B 0.00
Longeveron (LGVN) United States $0.029B 0.00
Chemomab Therapeutics (CMMB) Israel $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Orgenesis (ORGS) United States $0.028B 0.00
Cue Biopharma (CUE) United States $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
GeoVax Labs (GOVX) United States $0.026B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.024B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
NKGen Biotech (NKGN) United States $0.022B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
BioAffinity Technologies (BIAF) United States $0.022B 0.00
HCW Biologics (HCWB) United States $0.022B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.022B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Athira Pharma (ATHA) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.016B 0.00
Galecto (GLTO) Denmark $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Turnstone Biologics (TSBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
IN8bio (INAB) United States $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
ANEW Medical (WENA) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Tenax Therapeutics (TENX) United States $0.013B 0.00
Apollomics (APLM) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
Cadrenal Therapeutics (CVKD) United States $0.011B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Forte Biosciences (FBRX) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Carmell (CTCX) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Kineta (KA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Kintara Therapeutics (KTRA) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Hoth Therapeutics (HOTH) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Organovo Holdings (ONVO) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
COSCIENS Biopharma (CSCI) Canada $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
NuCana (NCNA) United Kingdom $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Trevena (TRVN) United States $0.006B 0.00
Cingulate (CING) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Notable Labs (NTBL) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Citius Oncology (CTOR) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Telesis Bio (TBIO) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
GRI Bio (GRI) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00